Bryan Olin

SVP & Head, Product Development, Neuromodulation at LivaNova

Dr. Olin joined Cyberonics in May 2009 as Vice President, Quality. In August 2009, he assumed additional responsibility for Clinical Affairs, and in April 2011, his responsibilities were expanded again to include Regulatory Affairs. With the 2015 merger between Cyberonics and Sorin, his responsibilities expanded to include corporate-wide responsibilities for the clinical, quality, and regulatory affairs function at LivaNova. Presently, his responsibilities focus on the Neuromodulation business unit where he oversees operations, R&D, and market access, in addition to his previous responsibilities for clinical and medical affairs, quality, regulatory affairs, and strategic portfolio initiatives.

Prior to May 2009, Olin was employed at Zeltiq Aesthetics, Inc., a privately held medical technology company in the San Francisco area, where he served as Sr. Director, Quality Assurance. Between 1999 and 2007, Olin was employed at the LifeScan and Cordis companies of Johnson & Johnson, holding several positions of increasing responsibility in quality assurance, statistics, and clinical data management. Olin began his career with Procter & Gamble in 1993 after obtaining his Ph.D. in statistics from Iowa State University.

Links

Previous companies

MDIC logo
Life Scan logo
Procter & Gamble logo

Timeline

  • SVP & Head, Product Development, Neuromodulation

    Current role

  • Senior Vice President, Clinical, Quality Assurance & Regulatory Affairs

View in org chart